Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

Overview of attention for article published in Arthritis Research & Therapy, March 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 4,925 followers.

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis #lymphoma #lymsm https://t.co/smnrF6rDaq

23 Mar 2022

Reply Repost Favourite

RT @Lymphoma_Papers: Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic art…

22 Mar 2022

Reply Repost Favourite

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis #lymphoma #lymsm https://t.co/2svAFcFyLT

22 Mar 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.